These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1511635)

  • 21. In vivo and in vitro study of several pharmacodynamic effects of meropenem.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Scand J Infect Dis; 1995; 27(5):469-74. PubMed ID: 8588137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
    Renneberg J; Walder M
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1714-20. PubMed ID: 2511798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model.
    Lepak AJ; Marchillo K; Craig WA; Andes DR
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1258-64. PubMed ID: 25512404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of 327 clinical isolates to netilmicin.
    Digranes A; Ostervold B; Madsen ST; Solberg CO; Haeger K
    J Int Med Res; 1978; 6(5):409-13. PubMed ID: 100353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.
    Novelli A; Mazzei T; Fallani S; Cassetta MI; Conti S
    J Chemother; 1995 Aug; 7(4):355-62. PubMed ID: 8568546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic effects of ciprofloxacin, fleroxacin and lomefloxacin in vivo and in vitro.
    Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
    Chemotherapy; 1996; 42(5):354-62. PubMed ID: 8874975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved efficacy with nonsimultaneous administration of netilmicin and minocycline against methicillin-resistant Staphylococcus aureus in in vitro and in vivo models.
    Goto Y; Hiramatsu K; Nasu M
    Int J Antimicrob Agents; 1999 Jan; 11(1):39-46. PubMed ID: 10075276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
    Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vivo and in-vitro study of the postantibiotic effect of meropenem.
    Martín Caminero MM; Fuentes Martinez F; Izquierdo Izquierdo J; Gómez-Lus Centelles ML; Prieto Prieto J
    J Antimicrob Chemother; 1993 Dec; 32(6):917-8. PubMed ID: 8144441
    [No Abstract]   [Full Text] [Related]  

  • 34. The postantibiotic effect induced by antimicrobial combinations.
    Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
    Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invitro comparative evaluation of aminoglycosides at a cancer centre.
    Biswas SK; Kelkar RS
    Indian J Cancer; 2002; 39(4):135-8. PubMed ID: 12928571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Netilmicin resistance in Staphylococcus aureus.
    Baliga S; Shenoy S; Vidyalakshmi K; Dhanashree B
    Natl Med J India; 1999; 12(4):192. PubMed ID: 10573981
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Synergy between tobramycin and netilmicin on three strains of methicillin and gentamicin resistant staphylococci (S. epidermidis, S. aureus)].
    Ratovohery D; Assous MV; Gilly L; Brun T; Nevot P; Paul G
    Ann Med Interne (Paris); 1994; 145(4):234-7. PubMed ID: 8092647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
    Hybenová D; Majtán V
    Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of postantibiotic effects of imipenem and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Hostacká A
    Arzneimittelforschung; 1997 Aug; 47(8):965-7. PubMed ID: 9296285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.